Scurvy-induced pulmonary arterial hypertension
- 1 Pulmonary and Critical Care Department, Cleveland Clinic Foundation, Cleveland, Ohio, USA
- 2 Internal Medicine Department, Al Quds University, Abu Dis, State of Palestine
- 3 Oncology, Georgetown University, Washington, DC, USA
- Correspondence to Dr Jehad Azar; jehad.azar@gmail.com
Abstract
Pulmonary arterial hypertension (PAH) is a progressive disease of the pulmonary vasculature that results in precapillary pulmonary hypertension. PAH is caused by a group of clinical conditions involving multiple organ systems. Several cases have been reported in the literature demonstrating an association between vitamin C deficiency and PAH. Low endothelial nitric oxide levels in the pulmonary vasculature, combined with the inappropriate activation of hypoxia-inducible transcription factors, seen in patients with ascorbic acid deficiency, are believed to be the main contributors to the pathogenesis of pulmonary vasculopathy and the exaggerated pulmonary vasoconstrictive response seen in patients with scurvy-induced PAH. Vitamin C supplementation is considered the definitive treatment.
Background
Pulmonary hypertension (PH) is a major global health issue affecting all age groups. Present estimates suggest a PH prevalence of ∼1% of the global population. The prevalence of pulmonary arterial hypertension (PAH) is unknown in North America, while several European registries have reported rates between 5 and 52 per million.1 The COMPERA registry confirmed female predominance, with a mean age at diagnosis of 36 years.2 PH has also been associated with detrimental effects on the cardiovascular system. A study done in Amsterdam showed increased incidence of a high H2FPEF-score in patients with idiopathic PAH, which was associated with worse prognosis and concurrent findings of left ventricular diastolic dysfunction.3 PH is defined as a pulmonary mean arterial pressure ≥20 mm Hg at rest, precisely assessed by right heart catheterisation.4 PH is classified into five categories based on aetiology.5 The term PH is used when describing all five groups, while the term PAH specifically refers to group 1 PH, which is characterised by a pulmonary vascular resistance (PVR) above 3 Wood units.4
While clinical scurvy is rare in the USA, vitamin C deficiency can affect up to 7.1% of the population. It is found more commonly in areas of low socioeconomic status in developed countries, particularly among malnourished patients and those suffering from alcohol use disorder.6
In this paper, we report a case of PAH related to low levels of vitamin C, a severe yet reversible cause of PAH. This case emphasises that physicians must have a high index of suspicion for scurvy when evaluating PAH in patients with relevant medical and/or social history. We also present the results of a literature review on PH related to vitamin C deficiency.
Case presentation
A female patient in her 30s presented with an 8-week-history of progressive exertional dyspnoea, bilateral lower limb swelling as well as gingival bleeding. Her previous medical history was significant for obesity, major depression and generalised anxiety disorder.
On admission, physical examination showed palor, bilateral ecchymotic lesions involving the four extremities, mainly the lower limbs, bilateral lower limb pitting oedema, corkscrew hair, jugular venous distension, regular rapid heart sounds, a loud P2 and a pansystolic murmur heard best left of the xiphoid process.
Investigations
Laboratory investigations showed normal electrolyte levels as well as normal liver enzymes and coagulation panel, but mild hyperbilirubinemia (total bilirubin 1.3 mg/dL (normal 0.3–1 mg/dL), direct bilirubin 0.9 mg/dL (normal 0.1–0.3 mg/dL)) and acute kidney injury with creatinine of 1.6 mg/dL (normal range 0.8–1.2 mg/dL) and BUN 32 mg/dL (normal range 7–20 mg/dL). Remaining laboratory findings were unremarkable. Chest X-ray was positive for mild bilateral pleural effusion and cardiomegaly. ECG showed sinus tachycardia at 112 bpm, right axis deviation and right ventricular hypertrophy (RVH). Furthermore, there were signs of right atrial dilatation, manifested by a high amplitude P wave (P pulmonale) in limb lead 2 (figure 1). Pulmonary function tests showed no obstruction with Forced expiratory volume 1(FEV1)/Forced Vital Capacity (FVC) >70% predicted, FVC was 83% predicted, but her diffusing capacity for carbon monoxide was reduced to 61% predicted. Transthoracic echocardiogram (TTE) showed normal ejection fraction (EF) at 60% with normal left ventricular systolic and diastolic functions, moderately dilated right ventricle (figures 2 and 3), dilated right atrium, moderately reduced right ventricular systolic function, severe tricuspid regurgitation (TR), estimated pulmonary artery systolic pressure (PASP) of 56 mm Hg, (figure 4), flattening of the interventricular septum positive for D-sign (figure 5).
ECG: sinus tachycardia, right axis deviation, right ventricular hypertrophy and P pulmonale in lead II, suggesting right atrial dilatation.
TTE; parasternal long axis view: dilated right ventricle (red arrow), mild pericardial effusion (blue arrow). TTE, transthoracic echocardiogram.
TTE; apical four-chamber view: right atrial dilatation (red arrow) and right ventricular dilatation (blue arrow), the blue line shows the basal diameter is 4.3 cm (normal 3.29±0.47 cm). Flat interventricular septum. TTE, transthoracic echocardiogram.
TTE; parasternal short axis view with continuous wave Doppler interrogation across the tricuspid valve. The peak velocity is 3.22 m/s. The estimated pressure gradient between the right atrium and right ventricle is 41.5 mm Hg. Adding to this the right atrial pressure will give the estimated pulmonary artery systolic pressure of 56.5. TTE, transthoracic echocardiogram.
TTE; parasternal short axis view: dilated right ventricle (red arrow), with flattening of the interventricular septum during systole suggesting pressure overload (blue arrow), the positive ‘D shape’ sign. TTE, transthoracic echocardiogram.
Obstructive sleep apnoea was excluded by polysomnography a few months prior to her admission. High-resolution non-contrast chest CT showed no signs of interstitial lung disease; V/Q scan was interpreted as a low probability study with no mismatched defects, excluding chronic thromboembolic PH. Given the negative evaluation for a secondary aetiology, PAH was suspected, thus she underwent right heart catheterisation (RHC), with a mean PAP of 41 mm Hg. While pulmonary artery wedge pressure (PAWP) was within normal range, 11 mm Hg, the patient displayed high PVR (6 Wood units), and a cardiac index of 2.49 L/min/m2, CO 5 L/min. A series of tests including antinuclear antibodies, anti-Scl-70, anti-ribonucleoprotein, anticentromere, anti-double stranded DNA, ANCA (antineutrophilic cytoplasmic antibody), complement level C3 and C4, anti-RO, anti-LA antibodies, viral hepatitis serologies and HIV serologies returned negative. Furthermore, there was no recorded history of drug administration or family history of PAH, abdominal ultrasounds excluded cirrhosis, and duplex vascular ultrasound showed no signs of portal hypertension. She denied anorexigenic medications or other medications known to cause pulmonary vasculopathy, but her reviewed history revealed that her diet was significantly unbalanced. Given her socioeconomic status and history of mental illness, her diet had been lacking fruits and vegetables for the previous few years. Given the patient’s unbalanced diet history, ecchymosis, gingival bleeding, ulceration, PAH and extensive negative workup for other aetiologies, scurvy-induced pulmonary vasculopathy was suspected. Ascorbic acid level was ordered and found to be undetectable. She was subsequently started on vitamin C supplementation, tadalafil 40 mg/day and diuretics. A few days later, she showed signs of clinical improvement with stabilisation of her vital signs, and she was successfully weaned from oxygen and transferred to the regular nursing floor. Three weeks later, a repeat TTE showed normal right ventricular size and systolic function, with no further sonographic findings suggesting PH. She also had resolution of gingival bleeding, otomycosis, petechiae and dyspnoea. She was discharged home after dietary consultation and on continued oral vitamin C supplementation.
Outcome and follow-up
Shortly after the replenishment of vitamin C, the patient displayed significant clinical improvement. After 3 weeks, repeat imaging evidently indicated the resolution of any signs relating to PH. The patient was able to return to normal daily activity after offering comprehensive dietary counselling and oral vitamin C supplementation. At 3-month follow-up, the patient was completely asymptomatic. TTE was done and showed normal left and right chambers size, normal EF, normal right ventricular systolic function and no TR or signs of PH. The patient was counselled to continue taking vitamin C supplementation.
Discussion
PAH includes idiopathic PAH, drug/toxin-mediated PAH, heritable PAH as well as PH resulting from connective tissue disease, HIV infection, congenital heart disease with left-to-right shunting, schistosomiasis infection and portal hypertension. Two other rare forms of PAH include pulmonary veno-occlusive disease and pulmonary capillary hemangiomatosis.1 The pathogenesis of PAH is a proliferative vasculopathy, characterised by vasoconstriction, cell proliferation, concentric medial hypertrophy, fibrosis and plexiform lesions with thrombosis in situ of the small pulmonary arteries and arterioles. Pathologic findings include hyperplasia and hypertrophy of all three layers of the vascular wall of the pulmonary arteries (intima, media, adventitia), resulting in severe loss of cross-sectional area and increased right ventricular afterload.1
Scurvy-induced PAH is thought to occur as a result of the loss of the vasodilatory effect of ascorbic acid, whereby vitamin C increases synthesis of endothelial NO in the pulmonary circulation.7 Moreover, both iron and vitamin C are cofactors for prolyl hydroxylase enzymes, which are responsible for regulating hypoxia-inducible transcription factors (HIFs).8 Vitamin C deficiency, thus, contributes to unregulated HIF-mediated pulmonary vasoconstriction and subsequent PAH development. PAH related to vitamin C deficiency is reversible; however, the lack of reported cases in the literature often results in delayed diagnosis and potentially fatal disease.
Metabolism of L-arginine by the enzyme NO synthase (NOS) results in formation of a powerful vasodilator; NO (figure 6). The presence of a low endothelial NO level has been associated with the development of PAH. The endothelial NOS (eNOS) is the predominant source of NO in the endothelial cells of the pulmonary vasculature. NO acts by increasing cyclic guanosine monophosphate (cGMP) within the pulmonary artery smooth muscle cells, causing relaxation through activation of cGMP-dependent protein kinase. Lung specimens from subjects with PAH show reduced or absent eNOS expression and higher levels of asymmetric dimethyl L-arginine (ADMA), an eNOS inhibitor.9 Ascorbic acid has been shown to increase NO production within the endothelium by degrading ADMA. Additionally, vitamin C stabilises and increases eNOS cofactor tetrahydrobiopterin while inhibiting the arginase pathway that competes for arginine. Thus, deficiency of ascorbic acid decreases NO levels with subsequent vasoconstriction and eventual proliferative vasculopathy with PVR and proliferation involving all three layers of the vessel wall. Another important mechanism involved in the pathogenesis of scurvy-related pulmonary arterial vasculopathy is the inappropriate activation of HIF in the absence of hypoxia, leading to an exaggerated pulmonary vasoconstrictive response.10
Diagram illustrating the endothelial nitric oxide pathway. Endothelial nitric oxide synthase (eNOS) metabolises L-arginine into nitric oxide (NO), which in turn acts on guanylte cyclase (GC) to induce vascular smooth muscle relaxation (Laith A. Ayasa, Jehad Azar, et al. Scurvy-Induced Pulmonary Arterial Hypertension).
Vitamin C deficiency leading to PH has been reported in the medical literature, but it appears to be rare, or at least rarely recognised and reported. We present the results of a literature review of the topic, with the basic details of reported cases summarised in table 1.
Reported cases with PAH related to vitamin C deficiency, in comparison with the patient presented in this work
Report | Age (y)/gender | Presentation | mPAP (mm Hg) | PVR (Wood unit) |
PAWP | CO/CI | RVSP (mm Hg) |
Treatment |
Farrukh Abbas et al 6 | 50 /F | Dyspnoea, scurvy | NR | NR | NR | NR | NR | Ascorbate |
Singh et al 18 | 48 /F | Dyspnoea, scurvy | 41 | 13 | 5 | 2.7/NR | 84 | Ascorbate, inhaled epoprostenol |
Kupari et al 19 | 40 /F | Dyspnoea, scurvy | 48 | 14 | 3 | NR/2.7 | 52 | Ascorbate, sildenafil |
Ghulam et al 11 | 66 /M | Dyspnoea, scurvy | NR | NR | NR | NR | 97 | Ascorbate, bosentan |
Soichiro et al 12 | 73 /F | Dyspnoea, scurvy | 48 | NA | NL | NR/1.2 | 35 | Ascorbate |
Terry et al 13 | 6 /M | Painful multifocal bone lesions, dyspnoea | NR | NR | NR | NR | 78 | Inhaled NO, milrinone, ascorbate, sildenafil |
Marston e. al.20 | 48 /F | Dyspnoea, chest pain | 41 | 13 | 5 | NR/1.9 | 84 | Inhaled epoprostenol, vitamin C, sildenafil |
Gayen et al 14 | 60 /M | Exertional dyspnoea, ecchymosis | 41 | NR | 11 | 3.5/2.2 | NR | Vitamin C, vitamin D |
Shah et al 15 | 35 /F | Dyspnoea, ecchymosis | NR | NR | NR | NR | NR | Vitamin C |
Benjamin et al 16 | 17 /M | Chest pain, ecchymosis | NR | NR | NR | NR | NR | Ascorbic acid, cholecalciferol, iron |
Azar et al 17 | 73 /F | Dyspnoea, oral ulceration ecchymosis | 50 | 6.7 | 9 | 6/2.76 | 129 | Sildenafil |
Our case | F | Dyspnoea, gingival bleeding, ecchymosis | 41.6 | 6.12 | 11 | 5/2.49 | 56 | Vitamin C, ascorbate |
-
A, age; CI, cardiac index; CO, cardiac output; G, gender; mPAP, mean pulmonary arterial pressure; NL, normal; NR, not reported; PAWP, pulmonary artery wedge pressure; RSVP, right ventricular systolic pressure.
Abbas et al 6 described the case of a 50-year-old woman presenting with heavy menses, ecchymosis, exertional dyspnoea and jaundice. She was subsequently diagnosed with PH due to poor diet. Vitamin C level was very low. She was started on ascorbic acid supplementation with subsequent clinical recovery. Her TTE was reported as normal at her subsequent 4-week follow-up visit.
Ghulam Ali and Pepi11 described a 48-year-old woman with ecchymosis, exertional dyspnoea and oral ulceration. She underwent a TTE that suggested PH, which was confirmed by RHC. Shortly after admission, the patient’s condition deteriorated with development of severe cardiogenic shock after she was started on intravenous treprostinil. Additional history revealed that lettuce was the main component of her diet for the preceding year, leading to clinical suspicion for scurvy. Intravenous vitamin C supplementation was started with rapid clinical improvement after 36 hours. A repeat TTE 1 month later was normal.
Nagamatsu et al 12 described a 40-year-old woman who was admitted with ecchymosis, palpable purpura and dyspnoea. The patient was diagnosed with PH, which was confirmed on RHC. Epoprostenol infusion failed to significantly reduce the mean PAP. Further history revealed a very poor diet, and vitamin C level was undetectable. The patient was started on intravenous vitamin C supplementation as well as Sildenafil. Repeat TTE and RHC showed complete recovery.
Dean et al 13 described a 66-year-old man with coeliac disease presenting with progressive dyspnoea and ecchymosis. This patient was diagnosed with PH. Initially, he improved on diuretics and anticoagulation but was admitted a few months later with worsening symptoms. Repeat TTE revealed RVSP (right ventricular systolic pressure) of 80 mm Hg with no clinical improvement despite treatment with bosentan. During reassessment, the patient reported that his diet had been lacking fruits and vegetables for the past 8 months. Vitamin C level was undetectable, and he was started on vitamin C supplementation with clinical improvement, leading to a full recovery, as confirmed by a repeat TTE.
Nagamatsu et al 12 described a 73-year-old woman with a clinical presentation suggestive of scurvy in addition to exertional dyspnoea. In this case, the patient had severe PH on TTE. PAH was confirmed via RHC. A vasoreactivity test with adenosine infusion was positive. A detailed history revealed that the patient was sensitive to many foods, raising suspicion for scurvy-related PAH. Subsequent vitamin C level was undetectable, confirming the diagnosis. The patient was started on vitamin C therapy and nifedipine, and she reported complete recovery at 3-month follow-up, with a normal RVSP on TTE.
There has also been a reported case in the paediatric literature. Gayen et al 14 described a 6-year-old boy with a 3-month history of painful multifocal bone lesions who experienced cardiac arrest while undergoing bone marrow aspiration under sedation. The patient was successfully resuscitated but subsequently developed persistent tachycardia. TTE showed PH. Given PH and the bone lesions, ascorbic acid level was measured and found to be undetectable. Initially, he was given milrinone and inhaled NO, then switched to sildenafil and vitamin C. The patient underwent full recovery with a normal TTE at 4-week follow-up. It was hypothesised that his cardiac arrest was related to his previously undiagnosed PH.
Shah et al 15 described a 48-year-old woman developing rapidly progressive chest pain and shortness of breath. History revealed that during the past year, she also developed recurrent pericarditis, joint pain and a rash. Further investigation was undertaken and a TTE was done showing severe right ventricular dysfunction. RHC was done and showed elevated mean PAP of 41 mm Hg. Vasoreactivity testing was positive. The patient was started on epoprostenol, yet, continued to worsen clinically and had a persistently elevated PVR requiring vasopressors. Vitamin C levels were undetectable. The patient then disclosed that her diet consisted mainly of coffee, chocolate and iceberg lettuce. She started on oral vitamin C supplementation along with sildenafil therapy and showed a tremendous clinical improvement, along with normalisation of her vitamin C levels and TTE findings over the next 2 weeks.
Frank et al 16 reported a male patient in his 60s who was referred to an outpatient pulmonary clinic reporting of worsening exertional dyspnoea. During a hospitalisation for systemic hypertension, a TTE was done which showed mild right ventricular dilation. On further questioning, it was found that his diet mainly consisted of candy and sports drinks. RHC was done and showed an elevated mean PAP of 41 mm Hg. PAWP was normal and the pulmonary vessels showed strong response to vasodilator administration during catheterisation. Major causes of PH were excluded, biopsy of skin lesions showed findings supportive of vitamin C deficiency, which led to a vitamin C workup showing a level of less than 0.1 mg/dL. He was prescribed oral vitamins C and D daily. Over the next 5 months of therapy, his rash, joint pain, oedema and dyspnoea significantly improved. TTE was repeated and showed disappearance of right ventricular dilation and a significant drop of PASP. Notably, this case demonstrated how PAH was treated with vitamin C supplementation alone without iron supplementation or the use of PAH-specific therapy.
Azar et al 17 reported a 35-year-old woman presenting to the hospital with painful lower limb oedema, dyspnoea, gingival bleeding and ecchymosis that had progressively worsened over 6 months. Physical examination showed poor dental hygiene, corkscrew hair and crackles on the respiratory exam. Vasculitis was suspected and glucocorticoids were administered but therapy failed. Laboratory findings were significant for anaemia, thrombocytopenia and elevated BNP levels. Urine toxicology screen was positive for benzodiazepine and opioids. Given her physical examination and the history of drug abuse, a nutritional deficiency was suspected and she was started on empirical vitamin C supplementation. TTE revealed severe PAH. Vitamin C levels came back undetectable; the patient continued taking vitamin C supplementation and showed marked improvement. RHC done 2 weeks after discharge showed complete resolution of the PAH.
Frank et al 16 described a 17-year-old man who presented to the emergency department reporting of chest pain, leg pain and bruising without trauma. On further questioning, it was revealed that he had many episodes of gum bleeding and a poor diet. Physical examination showed a loud P2 along with symmetric bilateral pedal oedema and bilateral lower limb ecchymoses, petechiae and corkscrew hairs. TTE was done and showed evidence of PH with TR. Extensive work up was done revealing undetectable levels of vitamin C, along with low levels of iron and vitamin D. The patient was admitted and treated with vitamin C and D supplementation along with iron. Follow-up TTE 1 and 6 months after discharge showed complete resolution of PH and TR.
Finally, Azar et al,17 described a patient who presented with progressive exertional dyspnoea and signs of advanced right heart failure. The initial diagnostic workup did not reveal any significant findings. Her ECG showed right axis deviation, as well as RVH, right bundle branch block and right ventricular strain. The patient’s TTE showed a severely dilated right ventricle with moderately reduced function. Subsequent RHC confirmed the diagnosis of PAH, and shortly after admission, the patient developed severe cardiogenic shock refractory to maximal supportive management including pulmonary vasodilators. Laboratory data showed the patient’s ascorbic acid level as zero; however, she passed away before supplementation with vitamin C. This was the only reported case where the patient did not survive; in all other reviewed cases, patients showed complete recovery after appropriate treatment with vitamin C.
Learning points
-
Pulmonary arterial hypertension (PAH) related to vitamin C deficiency can occur due to non-hypoxic activation of HIF and low nitric oxide levels in the pulmonary vasculature. This has been shown to cause pulmonary vascular disease and an excessive pulmonary vasoconstrictive response.
-
Physicians must have a high index of suspicion for scurvy-induced PAH in patients presenting with clininical picture suggestive of PAH and scurvy who are of low socioeconomic status, malnourished or elderly and/or are suffering from neglect, alcoholism or mental illness.
-
PAH related to vitamin C deficiency is a reversible life threatining disease, immediate supplementation of vitamin C is considered a curative treatment, preventing an otherwise fatal outcome.
Ethics statements
Patient consent for publication
Footnotes
-
Contributors JA, MA, YJ and LAA contributed in the preparation and revision of this manuscript. JA: patient diagnosis and management, collection and assembly of data, manuscript writing and editing, literature revision and review, final approval of manuscript, accountable for all aspects of the work. MA: manuscript writing and editing, literature revision and review, final approval of manuscript, accountable for all aspects of the work. YJ: manuscript writing and editing, literature revision and review, final approval of manuscript, accountable for all aspects of the work. LAA: manuscript writing and editing, literature revision and review, final approval of manuscript, accountable for all aspects of the work.
-
Funding The authors have not declared a specific grant for this research from any funding agency in the public, commercial or not-for-profit sectors.
-
Case reports provide a valuable learning resource for the scientific community and can indicate areas of interest for future research. They should not be used in isolation to guide treatment choices or public health policy.
-
Competing interests None declared.
-
Provenance and peer review Not commissioned; externally peer reviewed.
-
© BMJ Publishing Group Limited 2023. No commercial re-use. See rights and permissions. Published by BMJ.
- © BMJ Publishing Group Limited 2023. No commercial re-use. See rights and permissions. Published by BMJ.
References
Use of this content is subject to our disclaimer